Hisham Khalifa MD1, Ahmed Touny MD1 , Ihab Saad1 , Ahmed Abd elmaabood2 , Iman Hussein3 , Sherif Maamoon1
Mohamed Abd El-Moneim El-Masry(MD); Muhammad El Marzouky (MD); Yehia Fayez (Msc)
Ahmed M.S.M. Marzouk MD, Hany M.S. Mikhail MD, Abdrabou N Mashhour MD, Emad Fathi MSC
Mohamed Abd El-Moneim El-Masry(MD); Hussein Oukasha(MD)
Mohamed El-Maadawy, MD & Amr Abdelraheem, MD.
Mohamed I Abdelaziz, MD, Salah S. Soliman,MD, Hany F Habashy
Wael L. Tobar, A Ayad MD, A Morad* MD
Haidy N. Ashem MD. and Mohamed Yehia MD.
Ahmed Touny MD, Amr Selim. MD
Ayman M. A. Ali MD. & Ahmed Gaber Mahmoud MD
Ahmed Ali Ebrahiem Ali, M.Sc.
Amr Ibrahim Fouad (MD), Ashraf AbolFottoh (M), Sameh El Noamany Mohamed Hazem (MD)
Ahmed Samir Hosny.M.D.MRCS (Ed); Mohamed El Maadawy. M.D
Waheed Yousry Gareer MD, Mohamed El-Sayed Safa MD, Amr Seliem MD
A comparative Study of 3 cm and 6 cm Pre-pyloric Starting Point for Sleeve Gastrectomy as Regard Post-operative Weight Loss and Vomiting
Laparoscopic sleeve gastrectomy (LSG) is gaining popularity as a primary, staged and revisional
operation for its proven safety and simplicity, as well as short-term and mid-term efficacy. Some evidence
has shown that sleeve gastrectomy and similar procedures can be complicated by significant post-operative
reflux symptoms. With an intact pylorus, severely restricted stomach capacity, and physiologically
disrupted motility possibly creating stasis, one would expect that LSG would not be likely to relieve
heartburn reflux symptoms, as does LRYGB. Methods: This was a randomly selected prospective study
carried out on morbidly obese patients presented to Kasr El-Aini teaching hospital during the period from
January 2013 to March 2014, where sixty patients underwent sleeve gastrectomy. These patients grouped
into two groups according to the starting point of resection of the stomach; group (A) started 3cm from the
pylorus towards the gastro-esophageal junction and group (B) 6cm from the pylorus. The decision to do 3
cm resection or 6 cm resection randomly selected. These patients followed over a period of 6 months for
post -operative nausea; vomiting and reflux symptoms and their weight loss. Results: The overall patients’
weight loss percentage ranged from 30 to 86.9 % excess body weight loss with a mean of 60 %. In group A
(3 cm), patients’ weight loss percentage ranged from 31.2 to 86.9 % excess body weight loss with a mean of
60.9%, however, in group B (6 cm), patients’ weight loss percentage ranged from 30 to 83.5 % excess body
weight loss with a mean of 61.1%. In this study, (41.7%) of patients lost (40-60%) of their excess body
weight within 6 months without significance to any group or by other mean (91.7%) of patients lose > 40%
of their body weight at 6 months with no significance to 6 cm or 3 cm groups as seen from P-value 0.610.
There was no major complications (e.g.; leakage, bleeding, pulmonary embolism or death). However,
minor complications in the form of nausea, vomiting and reflux were more with 3 cm group (96.6%) as
compared to 6 cm group (67.9%). There was a strong significant difference between both groups can be
seen in the P-value (0.003). Conclusion: The majority of patients (88.3%) were satisfied from the
procedure and its results with no statistically significant difference between both groups in terms of weight
loss, decreased appetite or patient satisfaction.
Key words: Sleeve gastrectomy, Morbid obesity, Bariatric surgery.